Lauren Coyle, Commissioning Editor of Immuno-Oncology Insights, speaks with Aakash Desai, Medical Oncologist, O'Neal Comprehensive Cancer Center at UAB, about the advancements in I-O combinations and the challenges with trial design, biomarker integration, and managing synergistic toxicities.
No takes yet. Share an insight, caveat, or question.
Anushka Desai (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: